Get Vaccinated Report Abuse/Neglect Sign up for E-news! Reproductive Health 988: 24/7 LIfeline
NMDOH Logo

Zoonotic Disease Program

Resources


USDA/APHIS - APHIS Recommendations for HPAI H5N1 Virus in Livestock

USDA/APHIS - APHIS Recommendations for HPAI H5N1 Virus in Livestock

USDA/APHIS - APHIS Recommendations for HPAI H5N1 Virus in Livestock

USDA/APHIS - APHIS Recommendations for HPAI H5N1 Virus in Livestock

USDA/APHIS - Confirmed Cases HPAIDC (HPAI-A H5N1)

USDA/APHIS - Confirmed Cases HPAIDC (HPAI-A H5N1)

USDA/APHIS - Confirmed Cases HPAIDC (HPAI-A H5N1)

USDA/APHIS - Confirmed Cases HPAIDC (HPAI-A H5N1)

USDA/APHIS - Highly Pathogenic Avian Influenza

USDA/APHIS - Highly Pathogenic Avian Influenza

USDA/APHIS - Highly Pathogenic Avian Influenza

USDA/APHIS - Highly Pathogenic Avian Influenza

USDA/APHIS - HPAIDC FAQ Factsheet

USDA/APHIS - HPAIDC FAQ Factsheet

USDA/APHIS - HPAIDC FAQ Factsheet

USDA/APHIS - HPAIDC FAQ Factsheet

USDA/APHIS - HPAIDC FAQ Factsheet - SPANISH

USDA/APHIS - HPAIDC FAQ Factsheet - SPANISH

USDA/APHIS - HPAIDC FAQ Factsheet - SPANISH

USDA/APHIS - HPAIDC FAQ Factsheet - SPANISH

USDA/APHIS - Testing Recommendations in Cattle

USDA/APHIS - Testing Recommendations in Cattle

USDA/APHIS - Testing Recommendations in Cattle

USDA/APHIS - Testing Recommendations in Cattle

Using Repellent to Protect against Mosquito-Borne Illnesses

Using Repellent to Protect against Mosquito-Borne Illnesses

Using Repellent to Protect against Mosquito-Borne Illnesses

Insect repellents registered by the EPA can be expected to repel these mosquitoes, provided the EPA-approved labeling says the product is for use to protect against mosquitoes in general or against Aedes mosquitoes in particular.

West Nile Virus

West Nile Virus

West Nile Virus

West Nile virus is most commonly transmitted to humans by mosquitoes. You can reduce your risk of being infected by using insect repellent and wearing protective clothing to prevent mosquito bites.

Zika Care Connect

Zika Care Connect

Zika Care Connect

Zika Care Connect aims to improve access to specialty healthcare services for the management of Zika virus infection during pregnancy and outcomes in infants caused by Zika. The program targets the most important and removable barriers to care, as identified by maternal and pediatric care experts. We focus on women infected with Zika during pregnancy, as well as infants born to mothers with laboratory evidence of Zika.

Zika Virus Information

Zika Virus Information

Zika Virus Information

Zika virus is spread to people through mosquito bites. The most common symptoms of Zika virus disease are fever, rash, joint pain, and conjunctivitis (red eyes). The illness is usually mild with symptoms lasting from several days to a week. Severe disease requiring hospitalization is uncommon.

Zika Virus Information for Healthcare Providers

Zika Virus Information for Healthcare Providers

Zika Virus Information for Healthcare Providers

This page contains a variety of resources on Zika virus for healthcare providers.

Zika Virus Information for Pregnant Women

Zika Virus Information for Pregnant Women

Zika Virus Information for Pregnant Women

Zika virus can be spread from a pregnant woman to her fetus and has been linked to a serious birth defect of the brain called microcephaly in babies of mothers who had Zika virus while pregnant. Other problems have been detected among fetuses and infants infected with Zika virus before birth, such as absent or poorly developed brain structures, defects of the eye, hearing deficits, and impaired growth.

Zika Virus Travel Information

Zika Virus Travel Information

Zika Virus Travel Information

This resource contains the latest Zika virus travel information.

« First | Prev | 1 | 2 | Next | Last »